Form 4 holding
Director
Amneal Pharmaceuticals, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 113,944
- Estimated value
- $1,972,370
- Report date
- 17 Sep 2026
- Price
- $17.31
- Ownership
- By Trust
J. Kevin Buchi - Director at Amneal Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- AMRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by J. Kevin Buchi since 21 Oct 2025
Reported holdings for J. Kevin Buchi in Amneal Pharmaceuticals, Inc.
Form 4 holding
Director
Amneal Pharmaceuticals, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 75,077
- Estimated value
- $1,299,582
- Report date
- 17 Sep 2026
- Price
- $17.31
- Ownership
- Direct
Form 4 holding
Director
Amneal Pharmaceuticals, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 19,824
- Estimated value
- $0
- Report date
- 06 May 2026
- Price
- $5.31
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
Form 4 holding
Director
Amneal Pharmaceuticals, Inc.
- Security class
- Stock Option
- Shares / value
- 0
- Estimated value
- Report date
- 11 Sep 2026
- Price
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
Transaction history for J. Kevin Buchi in Amneal Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.